Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens.
Laosinchai-Wolf W, Ye F, Tran V, Yang Z, White R, Bloom K, Choppa P, Labourier E
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of using FFPE colorectal carcinoma specimens on KRAS mutation status determination using a PCR-based method with fluorescent bead detection and sequencing. No details of specimen handling are given and the preservation of the reference specimen is unspecified.
Summary of Findings
KRAS mutational status was properly determined in all 43 mutation-positive specimens and 11 mutation-negative specimens. However, one specimen failed to amplify in 1 of 2 assays and another specimen was a weak positive in only one of two replicates. Sequencing only agreed with PCR-based assays in 80% of specimens, with 20.7% of KRAS mutation-positive specimens identified as wildtype by sequencing but all KRAS mutation-negative specimens properly identified.
Biospecimens
TissueColorectalPreservation Types
FormalinNone (Fresh)Diagnoses
NeoplasticCarcinomaPlatforms
DNAPCRDNASNP assayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Preservation Type of fixation/preservation Formalin (buffered)None (fresh)SNP assay Specific Technology platform PCR based method with fluorescent bead detectionSequencing